Joseph Group Capital Management »

Regeneron Pharmaceuticals shares owned by Joseph Group Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Joseph Group Capital Management from 13F filings

Historical chart of Joseph Group Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Joseph Group Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Joseph Group Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 14 771.86

More positions owned by Joseph Group Capital Management

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Tips Etf (SCHP)
Financial Invs Tr Corecommodity Na (CCNR)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Wisdomtree Tr Glb High Div Fd (DEW)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Invesco Exchange Traded Fd T S&p500 Eql Fin (RSPF)
Lam Research Corporation
Parker-Hannifin Corporation (PH)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Joseph Group Capital Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals